Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-10 12:14 pm Purchase | 13G | VERTEX PHARMACEUTICALS INC VRTX | Capital World Investors | 25,902,938 10% | 3,822,731 (+17.31%) | View |
| 2024-02-13 5:17 pm Purchase | 13G | VERTEX PHARMACEUTICALS INC VRTX | VANGUARD GROUP INC | 22,281,729 8.65% | 734,826 (+3.41%) | View |
| 2024-02-09 6:19 pm Purchase | 13G | VERTEX PHARMACEUTICALS INC VRTX | Capital World Investors | 22,080,207 8.6% | 9,140,888 (+70.64%) | View |
| 2024-02-09 10:05 am Sale | 13G | VERTEX PHARMACEUTICALS INC VRTX | FMR LLC | 12,981,286 5.037% | -4,895,488 (-27.38%) | View |
| 2024-01-25 1:48 pm Sale | 13G | VERTEX PHARMACEUTICALS INC VRTX | BlackRock Inc. BLK | 21,881,203 8.5% | -2,360,234 (-9.74%) | View |
| 2023-06-05 4:10 pm Sale | 13D | KYMERA THERAPEUTICS INC KYMR | VERTEX PHARMACEUTICALS INC VRTX | 0 0% | -3,151,121 (Position Closed) | View |
| 2023-02-13 2:49 pm Purchase | 13G | VERTEX PHARMACEUTICALS INC VRTX | Capital World Investors | 12,939,319 5% | 5,564,740 (+75.46%) | View |
| 2023-02-09 12:39 pm Purchase | 13G | VERTEX PHARMACEUTICALS INC VRTX | FMR LLC | 17,876,774 6.964% | 8,643,205 (+93.61%) | View |
| 2023-02-09 11:35 am Purchase | 13G | VERTEX PHARMACEUTICALS INC VRTX | VANGUARD GROUP INC | 21,546,903 8.39% | 1,391,061 (+6.90%) | View |
| 2023-01-24 1:56 pm Purchase | 13G | VERTEX PHARMACEUTICALS INC VRTX | BlackRock Inc. BLK | 24,241,437 9.4% | 296,506 (+1.24%) | View |
| 2022-02-14 2:34 pm Sale | 13G | VERTEX PHARMACEUTICALS INC VRTX | PRICE T ROWE ASSOCIATES INC | 5,421,291 2.1% | -14,204,917 (-72.38%) | View |
| 2022-02-10 08:42 am Sale | 13G | VERTEX PHARMACEUTICALS INC VRTX | VANGUARD GROUP INC | 20,155,842 7.93% | -277,208 (-1.36%) | View |
| 2022-02-09 10:01 am Sale | 13G | VERTEX PHARMACEUTICALS INC VRTX | FMR LLC | 9,233,569 3.631% | -4,273,301 (-31.64%) | View |
| 2022-02-01 5:08 pm Sale | 13G | VERTEX PHARMACEUTICALS INC VRTX | BlackRock Inc. BLK | 23,944,931 9.4% | -323,964 (-1.33%) | View |
| 2021-02-16 12:23 pm Sale | 13G | VERTEX PHARMACEUTICALS INC VRTX | PRICE T ROWE ASSOCIATES INC | 19,626,208 7.5% | -4,899,697 (-19.98%) | View |
| 2021-02-10 12:00 pm Purchase | 13G | VERTEX PHARMACEUTICALS INC VRTX | VANGUARD GROUP INC | 20,433,050 7.86% | 338,816 (+1.69%) | View |
| 2021-02-08 10:35 am Sale | 13G | VERTEX PHARMACEUTICALS INC VRTX | FMR LLC | 13,506,870 5.194% | -10,776,092 (-44.38%) | View |
| 2021-02-01 08:23 am Purchase | 13G | VERTEX PHARMACEUTICALS INC VRTX | BlackRock Inc. BLK | 24,268,895 9.3% | 3,152,074 (+14.93%) | View |
| 2020-09-03 4:12 pm Purchase | 13D | KYMERA THERAPEUTICS INC KYMR | VERTEX PHARMACEUTICALS INC VRTX | 3,151,121 7.1% | 3,151,121 (New Position) | View |
| 2020-02-14 1:29 pm Sale | 13G | VERTEX PHARMACEUTICALS INC VRTX | PRICE T ROWE ASSOCIATES INC | 24,525,905 9.5% | -1,223,506 (-4.75%) | View |